MetaVia Inc. Q1 2025 10-Q Filed
Ticker: MTVA · Form: 10-Q · Filed: May 14, 2025 · CIK: 1638287
| Field | Detail |
|---|---|
| Company | Metavia INC. (MTVA) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
MetaVia Inc. 10-Q filed for Q1 2025. Financials look stable.
AI Summary
MetaVia Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as NeuroBo Pharmaceuticals, Inc. and Gemphire Therapeutics Inc., is based in Cambridge, MA. The filing covers the first quarter of 2025 and includes financial data such as common stock, additional paid-in capital, and retained earnings as of March 31, 2025, and December 31, 2024.
Why It Matters
This filing provides a snapshot of MetaVia Inc.'s financial health and position at the end of the first quarter of 2025, crucial for investors and stakeholders to assess the company's performance.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial information without immediate red flags.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Financial data as of this date)
- 2024-12-31 — Previous Year End Date (Financial data as of this date)
Key Players & Entities
- MetaVia Inc. (company) — Filer
- NeuroBo Pharmaceuticals, Inc. (company) — Former company name
- Gemphire Therapeutics Inc. (company) — Former company name
- 20250331 (date) — Period of report
- 20250514 (date) — Filing date
- Cambridge, MA (location) — Business address
FAQ
What was MetaVia Inc.'s former name before NeuroBo Pharmaceuticals, Inc.?
MetaVia Inc. was formerly known as Gemphire Therapeutics Inc. before becoming NeuroBo Pharmaceuticals, Inc.
What is the SIC code for MetaVia Inc.?
The Standard Industrial Classification code for MetaVia Inc. is 2834, Pharmaceutical Preparations.
When was the name change from Gemphire Therapeutics Inc. to NeuroBo Pharmaceuticals, Inc.?
The date of the name change from Gemphire Therapeutics Inc. was 20150331.
What is the business address of MetaVia Inc.?
The business address of MetaVia Inc. is 545 Concord Avenue, Suite 210, Cambridge, MA 02138.
What is the filing date of this 10-Q report?
This 10-Q report was filed on 20250514.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding MetaVia Inc. (MTVA).